Prof Sir Mene Pangalos

Prof Sir Mene Pangalos is a distinguished scientist and pharmaceutical executive with an extensive career in drug discovery and development. He currently serves on the Advisory Board of Isomorphic Labs, bringing his wealth of experience to the organization.2

Career Highlights

AstraZeneca Leadership: Prof Pangalos held several high-ranking positions at AstraZeneca, including:

• Executive Vice President of BioPharmaceuticals R&D (January 2019 - Present)1
• Executive Chair of AstraZeneca Board Science Committee (2016 - Present)1
• Executive Vice President of Innovative Medicines & Early Clinical Development (IMED) Biotech Unit (April 2010 - December 2018)1

During his tenure at AstraZeneca, he led efforts in cardiovascular, renal, metabolism, respiratory, immunology, neuroscience, and microbial science research.1

Previous Roles: Before joining AstraZeneca, Prof Pangalos held leadership positions at other pharmaceutical companies:

• Senior Vice President at Pfizer (2008 - 2010)1
• Vice President of Neuroscience at Wyeth (2003 - 2008)1

Achievements and Contributions

Prof Pangalos has made significant contributions to the pharmaceutical industry:

• Helped create the 5R framework at AstraZeneca, which improved the success rate of pipeline molecules from 4% to 19% in five years1
• Led the transition of over 20 novel drug candidates into clinical development for various neurological and psychiatric diseases1
• Received a knighthood in the 2020 New Year Honours for services to UK science1

Education

• Ph.D. in Neuropharmacology of Alzheimer's Disease and Depression from University College London1
• Bachelor of Science in Biochemistry and Molecular Biology (First Class Honors) from Imperial College London1

Prof Sir Mene Pangalos continues to be an influential figure in the pharmaceutical industry, now contributing his expertise to Isomorphic Labs as a member of their Advisory Board.